Victor D. Acevedo, B.S., Baylor College of Medicine, Houston, TX. Abstract #3059. Conditional activation of FGF Receptor-1 leads to an irreversible prostate adenocarcinoma and allows for an epithelial to mesenchymal transition.
Guillermo N. Armaiz-Pena, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #5495. Estrous cycle modulates ovarian cancer growth.
Gabriela Andrea Balogh, Ph.D., Fox Chase Cancer Center, Philadelphia, PA. Abstract #1672. Identification of a unique genomic signature induced by early pregnancy in the human breast of postmenopausal women.
Omari J. Bandele, B.S., Vanderbilt Univ. School of Medicine, Nashville, TN. Abstract #769. Bioflavonoids as poisons of human topoisomerase alpha and beta.
Melanie C. Bocanegra, B.S., Stanford University School of Medicine, Stanford, CA. Abstract #4431. Functional dissection of the 11q14 amplicon in breast cancer implicates GAB2 as a driver oncogene.
Chastity Bradley, M.S., Vanderbilt University Medical Center, Nashville, TN. Abstract #1152. Carcinogen-induced histone alteration in normal human mammary epithelial cells.
Joann Brooks, Ph.D., Emory University/Winship Cancer Institute, Atlanta, GA. Abstract #2097. CXCR4/SDF-1 axis regulates HIF-1 mediated VEGF expression.
Vernon T. Cannon, M.D., Ph.D., Evanston Northwestern Healthcare, Evanston, IL. Abstract #2589. Eicosanoids of the omega-3 fatty acid family inhibit proliferation of normal and malignant ovarian epithelial cells compared to omega-6 fatty acids: The importance of diet modification for chemoprevention.
David J. Castro, B.S., Oregon State University, Corvallis, OR. Abstract #4210. The role of caffeine and epigallocatechin-3-gallate in green tea, added to maternal drinking water, on chemoprevention of transplacental cancer induced by dibenzo [a,l] pyrene (DBP).
Miquella G. Chavez, B.S., University of New Mexico, Albuquerque, NM. Abstract #2045. Dynamics of cell-cell junctions in squamous cell carcinoma.
Karen D. Cowden Dahl, Ph.D., University of New Mexico, Albuquerque, NM. Abstract #3074. PEA3 transcriptionally activates both MMP-9 and MMP-14 in response to EGF signaling in ovarian tumor cells.
Anatasha C. Crawford, B.S., Georgetown University, Washington, DC. Abstract #3623. The role of Bcl-2 in antiestrogen resistant breast cancer cells.
Roberto Diaz, M.D., Ph.D., Vanderbilt University Medical Center, Nashville, TN. Abstract #4657. Recombinant peptides as biomarkers for cancer response to tyrosine kinase inhibitors combined with radiation.
Katerina D. Fagan-Solis, B.S., University of Massachusetts, Amherst, MA. Abstract #5208. The role of SKP2 in the proliferative and aggressive nature of estrogen receptor negative breast cancer.
Chantel F. Fuqua, B.S., Meharry Medical College, Nashville, TN. Abstract #4461. IL-21 stimulates activation of STAT proteins including STAT2/4/6 and regulates cytokine and chemokine expression in human U937 leukemia cells.
Willietta Gibson, B.S., Medical University of South Carolina, Charleston, SC. Abstract #2115. PAX2 oncogene regulates human beta defensin-1 expression and mediated cell death in prostate cancer cell lines.
Hisani N. Horne, B.S., Duke University, Durham, NC. Abstract #1042. Hypermethylation of the MAL gene promoter in breast cancer.
Nikia A. Laurie, Ph.D., St. Jude Children's Research Hospital, Memphis, TN. Abstract #5564. Targeting the secondary mutation in retinoblastoma.
Catherine R. Lewis, B.S., Morehouse School of Medicine, Atlanta, GA. Abstract #4532. Structural and functional analysis of BRCA1 isoforms.
Claudia P. Miller, M.S., UT M.D. Anderson Cancer Center, Houston, TX. Abstract #2486. The novel proteasome inhibitor, NPI-0052, synergizes with HDAC inhibitors to trigger apoptosis in leukemia cells.
John K. Smith, B.S., University of Mississippi Medical Center, Jackson, MS. Abstract #2392. Identification of redox-regulatory cysteine residues in the catalytic domain of Janus kinase 2.
Jeanine A. Southerland, B.S., Winship Cancer Institute - Emory University, Atlanta, GA. Abstract #1310. CXCR4 and ABCG2 as cell surface biomarkers for poorly differentiated cancer stem cell population.
Shana J. Sturla, Ph.D., University of Minnesota, Minneapolis, MN. Abstract #1392. Investigating the mechanism of selective toxicity of antitumor acylfulvenes: Identification of depurinating acylfulvene-DNA adducts.
Brooke E. Sylvester, B.S., University of Chicago, Chicago, IL. Abstract #199. Disparities in colorectal cancer: Retrospective analysis of mismatch repair genes and molecular targets.
Gabriel J. Villares, B.S., UT M. D. Anderson Cancer Center, Houston, TX. Abstract #4713. Identification of novel metastasis-related signaling pathways in human melanoma following PAR-1 knockdown by lentiviral based siRNA.